Join
Live feed
·
INSIDERFilingvia Quantisnow
Outlook Therapeutics Inc. logo

SEC Form 4: Evanson Jeff sold $203,726 worth of shares (164,155 units at $1.24), decreasing direct ownership by 14% to 1,012,975 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OTLK (Outlook Therapeutics Inc.) and more on Quantisnow.